Search

Your search keyword '"Tolazamide"' showing total 277 results

Search Constraints

Start Over You searched for: Descriptor "Tolazamide" Remove constraint Descriptor: "Tolazamide"
277 results on '"Tolazamide"'

Search Results

Catalog

Books, media, physical & digital resources

4. Antidiabetic Agents

5. COMPARISON OF DIFFERENT COMPUTATIONAL APPROACHES FOR UNVEILING THE HIGH-PRESSURE BEHAVIOR OF ORGANIC CRYSTALS AT A MOLECULAR LEVEL. CASE STUDY OF TOLAZAMIDE POLYMORPHS.

6. Analysis of Hypoglycemic Drugs by Liquid Chromatography-Tandem Mass Spectrometry.

8. Characterization of tolazamide binding with glycated and normal human serum albumin by using high-performance affinity chromatography.

9. Studies from Federal University Rio Grande do Norte Have Provided New Information about Antidiabetic Agents (Dft Investigation of the Solid-state Properties and Hirshfeld Surface Analysis of Antidiabetic Drugs: Acetohexamide and Tolazamide).

11. COMPARISON OF DIFFERENT COMPUTATIONAL APPROACHES FOR UNVEILING THE HIGH-PRESSURE BEHAVIOR OF ORGANIC CRYSTALS AT A MOLECULAR LEVEL. CASE STUDY OF TOLAZAMIDE POLYMORPHS

12. Inhibition Performance of Some Sulfonylurea on Copper Corrosion in Nitric Acid Solution Evaluated Theoretically by DFT Calculations

13. Characterization of tolazamide binding with glycated and normal human serum albumin by using high-performance affinity chromatography

14. Theoretical and experimental investigations on vibrational and structural properties of tolazamide.

15. Drug-Polymer Interactions at Water-Crystal Interfaces and Implications for Crystallization Inhibition: Molecular Dynamics Simulations of Amphiphilic Block Copolymer Interactions with Tolazamide Crystals.

16. Tolazamide

17. Effect of pressure on two polymorphs of tolazamide: why no interconversion?

18. Studies of binding by sulfonylureas with glyoxal- and methylglyoxal-modified albumin by immunoextraction using affinity microcolumns

19. Characterization of the rat mesangial cell type 2 sulfonylurea receptor.

20. The crystal and molecular structure of 1-(Hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl) Urea: Tolazamide (CHNOS).

21. Augmentation of the effects of insulin and insulin-like growth factors I and II on glucose uptake in cultured rat skeletal muscle cells by sulfonylureas.

22. Isoenergetic Polymorphism: The Puzzle of Tolazamide as a Case Study

23. Theoretical and experimental investigations on vibrational and structural properties of tolazamide

24. Drug–polymer Interactions at Water–Crystal Interfaces and Implications for Crystallization Inhibition: Molecular Dynamics Simulations of Amphiphilic Block Copolymer Interactions with Tolazamide Crystals

25. Simultaneous Determination of Seven Sulfonylurea-Type Oral Anti-Diabetic Agents in Adulterated Dietary Supplements and Traditional Chinese Medicines by Ultraperformance Liquid Chromatography–Tandem Mass Spectrometry

26. Similar modes of inclusion in complexes of β-cyclodextrin with sulfonylureahypoglycemic drugs

27. 2-Deoxyglucose Tissue Levels and Insulin Levels Following Tolazamide Dosing in Normal and Obese Mice

28. Fibrinolytic Activity and Haemagglutination Inhibition Immunoassays

29. Virtual Screening of Natural and Synthetic Ligands Against Diabetic Retinopathy by Molecular Interaction With Angiopoietin-2

30. Determining the Growth Mechanism of Tolazamide by Induction Time Measurement

31. Amphiphilic Block Copolymer as a Crystal Habit Modifier

32. A CASE OF SULFONYLUREA INDUCED PHOTOTOXICITY IN AN ELDERLY SUBJECT - A RARE CASE REPORT

33. Detection of anti-diabetics in equine plasma and urine by liquid chromatography?tandem mass spectrometry

34. Efficacy of Sulfonylureas with Insulin in Type 2 Diabetes Mellitus

35. Screening, library-assisted identification and validated quantification of oral antidiabetics of the sulfonylurea-type in plasma by atmospheric pressure chemical ionization liquid chromatography–mass spectrometry

36. Evaluation of a novel non-porous membrane extraction probe to determine sulphonylureas in plasma with analysis by LC-MS/MS

37. Effects of oral antihyperglycemic agents on extracellular matrix synthesis by mesangial cells

38. Heterogeneity of the inhibitory influence of sulfonylureas on prostanoid-induced smooth muscle contraction

39. Phototoxicity to sulphonamide-derived oral antidiabetics and diuretics: investigations in hairless mice

40. Photohemolysis Due to Oral Antidiabetic Drugs

41. Preparation and in Vitro Dissolution Profiles of Tolazamide-Polyethylene Glycol Solid Dispersions

42. Spectrophotometric Determination of Some Pharmaceutical Compounds Using 2,2-Diphenyl-1-picrylhydrazyl

43. Is Combination Sulfonylurea and Insulin Therapy Useful in NIDDM Patients?: A metaanalysis

44. Spectrophotometric determination of some pharmaceutical amides through charge—transfer complexation reactions

45. Use of Sulfonylurea Agents in Older Diabetic Patients

46. Adjunctive Use of Tolazamide in Newly-Diagnosed Diabetic Children

47. Effect of Sulfonylureas Administered Centrally on the Blood Glucose Level in Immobilization Stress Model

48. Insulin and Synthetic Hypoglycemic Agents

49. Nitrosierungen an Hydrazinderivaten, 6. Mitt.: Neuartige Reaktion oraler Antidiabetica vom Sulfonylsemicarbazid-Typ unter nitrosierenden Bedingungen

50. Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K+ channel Kir6.2 combination expressed in HEK-293 cells